0134U CPT® code: payer coverage and prior authorization

Payer policies and prior authorization for 0134U

Payer coverage policies that name 0134U

0134U appears in 14 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Shield of California, Regence, UnitedHealthcare.

PayerPolicyRole in policyReviewedDocument
AetnaTumor Markers (0352)not coveredAug 25, 2026payer document
Blue Cross & Blue Shield of MississippiGenetic Cancer Susceptibility Panels Using Next Generation Sequencingunproven / investigationalpayer document
Blue Cross & Blue Shield of MississippiMolecular Testing For Germline Variants Associated With Ovarian Cancer Brip1 Rad51c Rad51d Nbn (A.2.04.149)listed, no stancepayer document
Blue Shield of CaliforniaGenetic Cancer Susceptibility Panels Using Next Generation Sequencing (2.04.93)listed, no stancepayer document
RegenceEvaluating the Utility of Genetic Panels (Genetic Testing 64)listed, no stanceJun 1, 2026payer document
UnitedHealthcareGenetic Testing for Hereditary Cancer (2026T0009UU)
Multigene Panel		listed, no stanceJul 1, 2026payer document
UnitedHealthcareGenetic Testing for Hereditary Cancer (CS049.AB)
Multigene Panel		listed, no stanceAug 1, 2026payer document
UnitedHealthcareGenetic Testing for Hereditary Cancer (for Kansas Only) (CS049KS.04)
Multi-Gene Panel		listed, no stanceAug 1, 2026payer document
UnitedHealthcareGenetic Testing for Hereditary Cancer (for Kentucky Only) (CS049KY.14)
Multigene Panel		listed, no stanceAug 1, 2026payer document
UnitedHealthcareGenetic Testing for Hereditary Cancer (for Nebraska Only) (CS049NE.F)
Multigene Panel		listed, no stanceSep 1, 2026payer document
UnitedHealthcareGenetic Testing for Hereditary Cancer (for New Mexico Only) (CS049NM.E)
Multigene Panel		listed, no stanceAug 1, 2026payer document
UnitedHealthcareGenetic Testing for Hereditary Cancer (for Ohio Only) (CS049OH.E)
Multi-Gene Panel		listed, no stanceMay 1, 2026payer document
UnitedHealthcareGenetic Testing for Hereditary Cancer (for Pennsylvania Only) (CS049PA.W)
Multi-Gene Panel		listed, no stanceMay 1, 2026payer document
UnitedHealthcareGenetic Testing for Hereditary Cancer (for Tennessee Only) (CS049TN.AA)
Multigene Panel		listed, no stanceAug 1, 2026payer document

Medicaid fee-for-service

Prior authorization required or conditional in IN, MS.

  • AZ: $748.39 (lab), effective Oct 1, 2026
  • FL: $404.13 (lab_independent, non-facility), effective Jan 1, 2026
  • IL: $523.87 (practitioner), effective Jan 1, 2025
  • IN: $636.13 (professional, Advanced Practice Nurse (85%), non-facility), effective Jul 1, 2024
  • KY: $748.39 (lab), effective Jan 1, 2026
  • MS: $673.55 (comprehensive), effective Jul 1, 2026
  • ND: $0.00 (physician), effective Aug 1, 2026
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.